Coherus BioSciences Inc.
www.coherus.com
Latest From Coherus BioSciences Inc.
Biocon And Mylan Prime Pegfilgrastim Expansion
Biocon-Mylan’s sBLA for pegfilgrastim made at a new Indian site gets an FDA go-ahead, facilitating a "multi-fold" scale up in capacity. But it will be interesting to watch how impactful this could be on market dynamics in the US, where more competition has arrived.
Biocon-Mylan Prime Pegfilgrastim Market Expansion
Biocon-Mylan’s sBLA approval for pegfilgrastim made at a new Indian site gets FDA go-ahead, facilitating a "multi-fold" scale up in capacity. But it will be interesting to watch how impactful this could be on market dynamics in the US, where more competition has arrived.
Lupin’s Karkaria Addresses Biosimilars Pushback
Lupin's biotech president notes push-back by innovator firms against biosimilars in the US parallels that witnessed when small molecule generic competition first emerged, but remains confident that biosimilars will gain traction. The executive also sees little need for separate interchangeability studies.
Lupin’s Karkaria On Biosimilars Pushback And Interchangeability
Lupin's biotech president notes push-back by innovator firms against biosimilars in the US parallels that witnessed when small molecule generic competition first emerged, but remains confident that biosimilars will gain traction. The executive also sees little need for separate interchangeability studies.
Company Information
- Industry
-
Biotechnology
- Large Molecule
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Dermatology
- Gastrointestinal
- Immune Disorders
- Musculoskeletal & Connective Tissue Disorders
- Ophthalmic
- Alias(es)
- BioGenerics Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Coherus BioSciences Inc.
- Senior Management
-
Dennis Lanfear, Chmn., Pres. & CEO
Jean-Frederic Viret, PhD, CFO
Vladimir Vexler, PhD, CSO
Barbara K Finck, MD, Acting CMO
Vince Anicetti, COO
Erik Wiberg, EVP, Corp. Dev. - Contact Info
-
Coherus BioSciences Inc.
Phone: (800) 794-5434
333 Twin Dolphin Dr., Ste. 600
Redwood City, CA 94065
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice